The evaluation of consuming evening primrose oil with misoprostol on cervical preparation before hysteroscopy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240812062730N1

Enrollment

102

Registered

2025-03-21

Start date

2024-09-26

Completion date

Unknown

Last updated

2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A study of cervical dilatation in hysteroscopy.

Interventions

Intervention group: Patients in the intervention group will be inserted vaginally in the back of the neck by the interventionist in two sessions, 6 and 2 hours before the operation. In the control gro

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Candidates for hystroscopy

Exclusion criteria

Exclusion criteria: Pregnancy Bleeding or trombofilic disease Inflammation in cervix or vagina Mulerian anomalies Hypertention or epilepsy Prohibition of using prostaglandins

Design outcomes

Primary

Measure	Time frame
The amount of mechanical dilatation needed during hysteroscope entry. Timepoint: During hysteroscopy. Method of measurement: Using Hegar to enter internal OS and measure its size.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKheyronnesa zibarzani

Oroumia University of Medical Sciences

Arzani1372@yahoo.com+98 44 3346 5079

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026